Baduanjin Practice Matches Brisk Walking for Blood Pressure Reduction Over One Year

High blood pressure affects approximately 1.3 billion people globally and remains one of the leading modifiable risk factors for heart attack and stroke. Clinical guidelines consistently recommend lifestyle intervention - primarily regular exercise - as a first-line approach before or alongside medication. The evidence base for this recommendation is strong. The implementation problem is equally well-established: many people do not sustain exercise programs over time, particularly those requiring equipment, gym memberships, or dedicated outdoor space.

Baduanjin, a standardized eight-movement qigong sequence practiced for more than 800 years in China, requires no equipment and minimal space. The routine takes 10 to 15 minutes to complete, integrates slow structured movement with controlled breathing and meditative focus, and can be performed by most adults without initial instruction beyond basic guidance. Because it operates at low to moderate intensity, it is considered suitable for people with cardiovascular risk who cannot safely perform high-intensity exercise.

Whether baduanjin actually lowers blood pressure as effectively as more vigorous exercise was an open question until a large randomized controlled trial, published in JACC: the Journal of the American College of Cardiology, provided a direct comparison.

Trial Design

The study enrolled 216 adults age 40 or older with systolic blood pressure in the 130-139 mmHg range - classified as stage 1 hypertension under American College of Cardiology and American Heart Association guidelines. Participants were recruited across seven community sites in China and randomly assigned to one of three groups: baduanjin practiced five days per week, self-directed exercise alone, or brisk walking.

The primary outcome was change in 24-hour ambulatory systolic blood pressure from baseline, measured at 12 weeks and 52 weeks. Twenty-four-hour measurement captures blood pressure patterns across the full day and night, providing a more complete picture than a single office reading. The trial ran for one full year.

Results

Compared to self-directed exercise, baduanjin reduced 24-hour systolic blood pressure by approximately 3 mmHg at both three months and one year. Office systolic blood pressure - the standard clinic measurement - fell by 5 mmHg. The magnitude of reduction is clinically meaningful: a 5 mmHg reduction in systolic blood pressure corresponds to approximately a 10 percent reduction in cardiovascular disease risk, and is comparable to the effect sizes seen in landmark trials of several first-line antihypertensive medications.

Baduanjin and brisk walking produced comparable outcomes at one year, with similar safety profiles. Neither intervention caused significant adverse events.

Notably, the blood pressure reductions were maintained at one year without ongoing monitoring - a critical finding for any lifestyle intervention. Programs that require professional supervision to sustain effects are inherently difficult to scale. Baduanjin's effects persisted independently, suggesting participants had genuinely integrated the practice rather than depending on external reinforcement.

Implications for Access

"Baduanjin has been practiced in China for over 800 years, and this study demonstrates how ancient, accessible, low-cost approaches can be validated through high-quality randomized research," said Harlan M. Krumholz, Editor-in-Chief of JACC and professor at the Yale School of Medicine. "The blood pressure effect size is similar to that seen in landmark drug trials, but achieved without medication, cost or side effects. This makes it highly scalable for community-based prevention, including in resource-limited settings."

"Given its simplicity, safety and ease at which one can maintain long-term adherence, baduanjin can be implemented as an effective, accessible and scalable lifestyle intervention for individuals trying to reduce their blood pressure," said Jing Li, senior author and Director of Preventive Medicine at the National Center for Cardiovascular Diseases in Beijing.

Limitations

The trial was conducted in seven Chinese communities, and its generalizability to populations unfamiliar with qigong-style movement practices has not been tested. The question of whether adherence and effects would replicate in Western contexts - where baduanjin is far less culturally embedded - cannot be answered from this trial alone. The study enrolled adults with stage 1 hypertension; effects in people with more severe or medication-resistant hypertension are unknown. The comparison arm of "self-directed exercise" is inherently difficult to standardize, and the actual exercise behaviors in that group may have varied considerably across participants.

The trial also does not address whether baduanjin reduces hard cardiovascular outcomes - heart attacks, strokes, cardiovascular mortality - which would require a much larger and longer study than any blood pressure trial.